Clinical Trial: Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07721012) titled 'Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)' on July 16.

Brief Summary: This trial is a randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase II clinical trial. Its purpose is to evaluate the efficacy and safety of Huanghou Zhixie Diwan in subjects with irritable bowel syndrome with diarrhea (Large Intestinal Damp-heat syndrome) after 4 weeks of treatment.

Study Start Date: July 31

Study Type: INTERVENTIONAL

Condition: Patients With Irritable Bowel Syndrome With Diarrhea

Intervention: DRUG: Huanghou Zhixie Diwan group

The prescription consists of Magnolia ...